144 related articles for article (PubMed ID: 8440076)
1. Human CD4 modulation in vivo induced by antibody treatment.
Horneff G; Guse AH; Schulze-Koops H; Kalden JR; Burmester GR; Emmrich F
Clin Immunol Immunopathol; 1993 Jan; 66(1):80-90. PubMed ID: 8440076
[TBL] [Abstract][Full Text] [Related]
2. Differential functional effects of a humanized anti-CD4 antibody on resting and activated human T cells.
Brett SJ; Rowan W; Smith M; Bartholomew M; Tite JP
Immunology; 1997 Jul; 91(3):346-53. PubMed ID: 9301522
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of cell surface CD4 molecule expression induced by anti-CD4 antibodies in human T lymphocytes.
Morel P; Vincent C; Wijdenes J; Revillard JP
Cell Immunol; 1992 Dec; 145(2):287-98. PubMed ID: 1451179
[TBL] [Abstract][Full Text] [Related]
4. Treatment of rheumatoid arthritis with an anti-CD4 monoclonal antibody.
Horneff G; Burmester GR; Emmrich F; Kalden JR
Arthritis Rheum; 1991 Feb; 34(2):129-40. PubMed ID: 1994909
[TBL] [Abstract][Full Text] [Related]
5. Anti-CD4 antibody treatment of patients with rheumatoid arthritis: II. Effect of in vivo treatment on in vitro proliferative response of CD4 cells.
Walker C; Herzog C; Rieber P; Riethmüller G; Müller W; Pichler WJ
J Autoimmun; 1989 Oct; 2(5):643-9. PubMed ID: 2572231
[TBL] [Abstract][Full Text] [Related]
6. A novel model for antigen-dependent activation of normal human T cells. Transmembrane signaling by crosslinkage of the CD3/T cell receptor-alpha/beta complex with the cluster determinant 2 antigen.
Suthanthiran M
J Exp Med; 1990 Jun; 171(6):1965-79. PubMed ID: 1972176
[TBL] [Abstract][Full Text] [Related]
7. Valency of CD3 binding and internalization of the CD3 cell-surface complex control T cell responses to second signals: distinction between effects on protein kinase C, cytoplasmic free calcium, and proliferation.
Ledbetter JA; June CH; Martin PJ; Spooner CE; Hansen JA; Meier KE
J Immunol; 1986 Jun; 136(11):3945-52. PubMed ID: 3084650
[TBL] [Abstract][Full Text] [Related]
8. An anti-CD4 antibody for treatment of chronic inflammatory arthritis.
Emmrich F; Horneff G; Becker W; Lüke W; Potocnik A; Kanzy U; Kalden JR; Burmester G
Agents Actions Suppl; 1991; 32():165-70. PubMed ID: 2069085
[TBL] [Abstract][Full Text] [Related]
9. Patterns of costimulation of T cell clones by cross-linking CD3, CD4/CD8, and class I MHC molecules.
Wacholtz MC; Patel SS; Lipsky PE
J Immunol; 1989 Jun; 142(12):4201-12. PubMed ID: 2470819
[TBL] [Abstract][Full Text] [Related]
10. Anti-CD2 monoclonal antibody-induced receptor changes: down modulation of cell surface CD2.
Lin J; Yon RW; Chavin KD; Qin L; Woodward J; Ding Y; Yagita H; Bromberg JS
Transplantation; 1995 Apr; 59(8):1162-71. PubMed ID: 7537394
[TBL] [Abstract][Full Text] [Related]
11. Activation of T cells by cross-linking an anti-CD3 antibody with a second anti-T cell antibody: mechanism and subset-specific activation.
Walker C; Bettens F; Pichler WJ
Eur J Immunol; 1987 Jun; 17(6):873-80. PubMed ID: 2439351
[TBL] [Abstract][Full Text] [Related]
12. The Epitope-Specific Anti-human CD4 Antibody MAX.16H5 and Its Role in Immune Tolerance.
Stahl L; Duenkel A; Hilger N; Tretbar US; Fricke S
Front Immunol; 2019; 10():1035. PubMed ID: 31178857
[TBL] [Abstract][Full Text] [Related]
13. Vascular cell adhesion molecule 1 induces T-cell antigen receptor-dependent activation of CD4+T lymphocytes.
Damle NK; Aruffo A
Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6403-7. PubMed ID: 1713678
[TBL] [Abstract][Full Text] [Related]
14. Preincubation with anti-CD4 influences activation of human T cells by subsequent co-cross-linking of CD4 with CD3.
Tsygankov AY; Bröker BM; Guse AH; Meinke U; Roth E; Rossmann C; Emmrich F
J Leukoc Biol; 1993 Nov; 54(5):430-8. PubMed ID: 8228621
[TBL] [Abstract][Full Text] [Related]
15. The effects of an anti-CD4 monoclonal antibody, keliximab, on peripheral blood CD4+ T-cells in asthma.
Kon OM; Sihra BS; Loh LC; Barkans J; Compton CH; Barnes NC; Larché M; Kay AB
Eur Respir J; 2001 Jul; 18(1):45-52. PubMed ID: 11510804
[TBL] [Abstract][Full Text] [Related]
16. Anti-CD2 antibodies induce T cell unresponsiveness in vivo.
Gückel B; Berek C; Lutz M; Altevogt P; Schirrmacher V; Kyewski BA
J Exp Med; 1991 Nov; 174(5):957-67. PubMed ID: 1682413
[TBL] [Abstract][Full Text] [Related]
17. Human resting B lymphocytes can serve as accessory cells for anti-CD2-induced T cell activation.
Hirokawa M; Gray JD; Takahashi T; Horwitz DA
J Immunol; 1992 Sep; 149(6):1859-66. PubMed ID: 1355500
[TBL] [Abstract][Full Text] [Related]
18. Treatment of rheumatoid arthritis with monoclonal CD4 antibody M-T151. Clinical results and immunopharmacologic effects in an open study, including repeated administration.
Reiter C; Kakavand B; Rieber EP; Schattenkirchner M; Riethmüller G; Krüger K
Arthritis Rheum; 1991 May; 34(5):525-36. PubMed ID: 2025306
[TBL] [Abstract][Full Text] [Related]
19. CD8+ T cells lyse autologous monocytes in the presence of anti-CD3 monoclonal antibody: association with interleukin-1 production.
Itoh K; Balch CM; Trial J; Platsoucas CD
Cell Immunol; 1988 Jul; 114(2):257-71. PubMed ID: 3260540
[TBL] [Abstract][Full Text] [Related]
20. Induction of suppressor cells to T- and B-cell proliferative responses and immunoglobulin production by monoclonal antibodies recognizing the CD3 T-cell differentiation antigen.
Kunicka JE; Platsoucas CD
Cell Immunol; 1988 Oct; 116(1):195-215. PubMed ID: 2901914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
